1. Size Exclusion Chromatography of Protein Biopharmaceuticals: Past, Present and Future
- Author
-
Fekete, S., Goyon, A., Jean-Luc Veuthey, and Guillarme, D.
- Subjects
Aggregate ,ddc:615 ,Fusion proteins ,Antibody drug conjugate ,Size-exclusion chromatography ,Monoclonal ,Hardware_ARITHMETICANDLOGICSTRUCTURES ,Antibody ,Biopharmaceuticals - Abstract
Size exclusion chromatography (SEC) is a historical technique, routinely applied for the separation of species possessing different molecular masses (sizes). It is considered as a reference method for the qualitative and quantitative analysis of protein aggregates. In the last few years,several improvements were brought to high performance SEC (HP-SEC or conventional SEC) in terms of particle size, inertness and column dimension. Today, SEC columns of smaller dimensions packed with sub-3 μm particles (also known as ultra-high performance SEC (UHPSEC)) are used, to obtain faster and better separation compared to HP-SEC. This paper discusses the possibilities and limitations of both HP-SEC and UHP-SEC and also describes some possible directions for future applications related to protein biopharmaceuticals analysis.
- Published
- 2018